🇯🇵 Japan Country × Condition
platinum sensitive ovarian cancer Clinical Trials in Japan
Active clinical trials for platinum sensitive ovarian cancer with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 2 // Recruiting: 2 Phases: Phase 3, Phase 2 // Updated: Daily
Total Trials
2
Recruiting Now
2
Country
🇯🇵 Japan
Active Trials in Japan (2)
NCT07225270 Phase 3
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy
Enrollment
528 pts
Country
🇯🇵 Japan
Genmab
View Trial → NCT07024784 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Enrollment
377 pts
Country
🇯🇵 Japan
AbbVie
View Trial → Frequently Asked Questions
How many platinum sensitive ovarian cancer clinical trials are active in Japan?
There are currently 2 active clinical trials for platinum sensitive ovarian cancer with sites in Japan, of which 2 are actively recruiting patients.
How can I join a platinum sensitive ovarian cancer clinical trial in Japan?
To join a platinum sensitive ovarian cancer clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are platinum sensitive ovarian cancer trials in Japan?
Active platinum sensitive ovarian cancer trials in Japan span Phase 3, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.